Premium
Progressive spinal axonal degeneration and slowness in ALS2‐deficient mice
Author(s) -
Yamanaka Koji,
Miller Timothy M.,
McAlonisDownes Melissa,
Chun Seung Joo,
Cleveland Don W.
Publication year - 2006
Publication title -
annals of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.764
H-Index - 296
eISSN - 1531-8249
pISSN - 0364-5134
DOI - 10.1002/ana.20888
Subject(s) - amyotrophic lateral sclerosis , motor neuron , sod1 , upper motor neuron , hereditary spastic paraplegia , neuroscience , biology , spinal cord , spasticity , pathology , medicine , disease , genetics , gene , phenotype , physical therapy
Objective Homozygous mutation in the ALS2 gene and the resulting loss of the guanine exchange factor activity of the ALS2 protein is causative for autosomal recessive early‐onset motor neuron disease that is thought to predominantly affect upper motor neurons. The goal of this study was to elucidate how the motor system is affected by the deletion of ALS2. Methods ALS2‐deficient mice were generated by gene targeting. Motor function and upper and lower motor neuron pathology were examined in ALS2‐deficient mice and in mutant superoxide dismutase 1 (SOD1) mice that develop ALS‐like disease from expression of an ALS‐linked mutation in SOD1. Results ALS2‐deficient mice demonstrated progressive axonal degeneration in the lateral spinal cord that is also prominent in mutant SOD1 mice. Despite the vulnerability of these spinal axons, lower motor neurons in ALS2‐deficient mice were preserved. Behavioral studies demonstrated slowed movement without muscle weakness in ALS2 −/− mice, consistent with upper motor neuron defects that lead to spasticity in humans. Interpretation The combined evidence from mice and humans shows that deficiency in ALS2 causes an upper motor neuron disease that in humans closely resembles a severe form of hereditary spastic paralysis, and that is quite distinct from amyotrophic lateral sclerosis. Ann Neurol 2006;60:95–104